Hoth Therapeutics Inc. (NASDAQ: HOTH) has been phenomenal in just the last two days, taking off abruptly from $3 to almost $11. A rise of such mighty proportions warrants a thorough look into this promising biotech stock. FDA Approves Hoth Therapeutics’ IND Application Cutting straight to the chase, the reason behind HOTH’s incredible takeoff links …
Futu Holdings Limited (NASDAQ: FUTU) has seen top-notch performance all through this year, without fail. It is one of the few mid-sized players on NASDAQ that have delivered quite the win to its shareholders. Only time will tell how far this beast flies, now that the management is shifting focus toward international expansion. FUTU’s Rock-Solid …
Palisade Bio Inc. (NASDAQ: PALI) is a pharmaceutical company that holds specialized expertise in the domain of the mucus barrier protecting the gastrointestinal tract. With this set of specialized skills, the company holds immense potential for seeing its pipeline develop into an enhanced product line. Its stock has been spontaneously surging as of late. PALI …
Palisade Bio Inc. (PALI) Stock Climbing with the Pump Read More »
First Wave BioPharma Inc. (NASDAQ: FWBI) is a biotech company with a focus on the gastrointestinal domain. Despite coming leaps and bounds within this specialist field, the company still awaits its breakthrough, which may come a lot sooner than the market anticipates. First Wave BioPharma to Participate in JP Morgan’s Investment Conference The recent news …
First Wave Biopharma (FWBI) Stock Anticipates Breakthrough Read More »
Dermata Therapeutics Inc. (NASDAQ: DRMA) is a biotechnology company, which, as its name suggests, operates in the realm of dermatology. It aims to make a breakthrough in acne treatment, with its DMT310 candidate, yet recent updates demonstrate that severe challenges still lie ahead for DRMA stock. Dermata Shares Underwhelming Updates Earlier this month, Dermata Therapeutics …
Dermata Therapeutics (DRMA) Stock Faces Challenges Ahead Read More »
Tuesday Morning Corporation (NASDAQ: TUEM) had been dealt a rough hand and has seen its stock drop from $68 to below $0.68, all in a single year. This morning, however, the market has surprisingly pushed up TUEM stock by 17%. TUEM Sees Correction After Plunge Tuesday Morning Corporation (TUEM) has had a rough year, but …
Tuesday Morning Corp. (TUEM) Stock Sees Upward Correction Read More »
Sesen Bio Inc. (NASDAQ: SESN) has made the news lately, as its merging partner, Carisma Therapeutics has gone on to up its dividend payment from $25 million to a whopping $70 million. This bodes well for the future of the combined entities and hints toward a path of shared value creation. Sesen Bio Shareholders Receive …
Sesen Bio Inc. (SESN) Shareholders Bear Fruits of Merger Read More »
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.